ONE DESIGN CENTER PLACE, BOSTON, MA
Reports Second Quarter 2025 Financial Results
Shareholder votes
Appoints Maha Radhakrishnan, M.D. to its Board of Directors
Results of Operations and Financial Condition
Costs Associated with Exit or Disposal Activities
Annual Report to Security Holders
Entrada Therapeutics Authorized for Phase 1/2 Study in Duchenne Muscular Dystrophy
Reports Fourth Quarter and Full Year 2024 Financial Results
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Submission Upload
Correspondence